CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 34 enrolled
Drug / intervention
Percutaneous deep vein arterialization +1 moreprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03321552
NCT03321552N/ACompleted
CompareCT.gov

Percutaneous Deep Vein Arterialization Post-Market Study

LimFlow SA·interventional·Posted Oct 25, 2017·Updated Jan 7, 2026

In Brief

A clinical study evaluating Percutaneous deep vein arterialization and LimFlow System for Critical Limb Ischemia. Completed, enrolled 34 participants across 12 sites in 5 countries.

Detailed Summary

The objective of this post-market study is to evaluate the safety and effectiveness of the LimFlow System in creating a below-the-knee arterio-venous fistula for venous arterialization in subjects with critical limb ischemia.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCritical Limb Ischemia
CountriesAustria, Germany, Netherlands, New Zealand, Singapore
Collaborators--

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedOct 25, 2017
Enrollment StartDec 15, 2017
Primary CompletionJan 23, 2025
TodayJul 2, 2026
Enrollment to primary: 7.1 yearsPosted 8.7 years ago

Interventions

Percutaneous deep vein arterializationprocedure

Creation of an arterio-venous fistula in the below-the-knee vasculature using the LimFlow System endovascular, minimally invasive approach

LimFlow Systemdevice

Creation of an arterio-venous fistula in the below-the-knee vasculature using the LimFlow System endovascular, minimally invasive approach